Agency
National Institute of Health (NIH)
Institute
Office of The Director, NCI (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CO074102-091
Application #
2304311
Study Section
Project Start
1987-09-26
Project End
1996-03-25
Budget Start
1994-09-26
Budget End
1996-03-25
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Program Resources, Inc.
Department
Type
DUNS #
City
Reston
State
VA
Country
United States
Zip Code
Asojo, Oluwatoyin A; Gulnik, Sergei V; Afonina, Elena et al. (2003) Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum. J Mol Biol 327:173-81
Asojo, Oluwatoyin A; Afonina, Elena; Gulnik, Sergei V et al. (2002) Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370. Acta Crystallogr D Biol Crystallogr 58:2001-8
Lunn, G; Phillips, L R; Pacula-Cox, C (1998) Reversed-phase high-performance liquid chromatography of 4-(2-pyridyl)-1-piperazinethiocarboxylic acid 2-[1-(pyridyl)ethylidene]hydrazide dihydrochloride (NSC 348977), a synthetic thiosemicarbazone with antitumor activity. J Chromatogr B Biomed Sci Appl 708:217-22
Mehta, R R; Graves, J M; Shilkaitis, A et al. (1998) Development of a new metastatic human breast carcinoma xenograft line. Br J Cancer 77:595-604
Silva, A M; Lee, A Y; Erickson, J W et al. (1998) Structural analysis of plasmepsin II. A comparison with human aspartic proteases. Adv Exp Med Biol 436:363-73
Mehta, R R; Hawthorne, M E; Graves, J M et al. (1998) Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells. Eur J Cancer 34:902-7
Shiao, Y H; Buzard, G S; Weghorst, C M et al. (1997) DNA template as a source of artifact in the detection of p53 gene mutations using archived tissue. Biotechniques 22:608-10, 612
Mazur, J; Jernigan, R L; Sarai, A (1996) Constructing optimal backbone segments for joining fixed DNA base pairs. Biophys J 71:1493-506
Fenton, R G; Steis, R G; Madara, K et al. (1996) A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma. J Immunother Emphasis Tumor Immunol 19:364-74
Chertov, O; Michiel, D F; Xu, L et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271:2935-40

Showing the most recent 10 out of 567 publications